VERTEX PHARMACEUTICALS INC. SCHEDULE 13G

Company

VERTEX PHARMACEUTICALS INC / MA

Filed

January 22, 2001

Accession Number

0000945621-01-000023

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →